Alexander Rudko has been the head of R&D-Center NovaMedica Innotech since 2017. He played one of the key roles in its creation and development. More information on the R&D-Center NovaMedica Innotech – here.
Alexander has more than 20 years of experience in the development of R&D in the Russian pharmaceutical industry. Over 200 medicines have been created by him personally or under his leadership. Before joining NovaMedica, Alexander worked for such big pharmaceutical companies as Pharmstandard, Stada-Nizhpharm and Akrikhin.
Alexander graduated from the Kursk State Medical University with a degree in Engineering and Technology of Pharmaceutical Manufacturing. He has an MBA of the Moscow International Higher Business School MIRBIS.
Shareholders
Pipeline
Media Center
-
2021 in Focus: Pharm Exec’s Annual Industry Outlook
15 January 2021
-
Research Eye stem cell transplant to treat blindness bolsters retinal function in monkeys
15 January 2021
-
Harnessing the power of a digital assistant to accelerate patient access
14 January 2021
-
A COVID-19 treatment candidate that fuses tiny antibodies from llamas and alpacas shows promise
14 January 2021